跳至主要内容
临床试验/CTRI/2025/05/086482
CTRI/2025/05/086482尚未招募2 期

A clinical study to evaluate the yoni sankirnta effect of yoni pichu with kapikacchu moola kwatha w.s.r . To vaginal laxity

Dr Khushbu kaushik1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2025年10月6日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
86
试验地点
1
主要终点
Improvement in vaginal laxity, tissue integrity and tone

研究概览

简要总结

Yoni-Shaithilya is made up of two words Yoni and Shaithilya. The word Yoni in Ayurvedic classics is used to denote genital tract or perineum as a whole, uterus and vaginal canal. The word Shaithilya means looseness or laxity; the quality or state of being lax. Ancient Acharyas have mentioned 20 types of Yoni Vyapad which includes almost all types of gynaecological disorders, developing due to vitiation of vata, pitta and kapha. But Yoni Shaithilya is not described as a disease in Ayurvedic literature. It is mentioned as a symptom of various types of Yonivyapads i.e. Vatala, Mahayoni, Prasamsini, Andini/Phalini yonivyapad .

 Vaginal laxity is the looseness of the vagina usually caused by physiological changes in a woman’s life, such as childbirth, weight fluctuations, and hormonal changes due to aging and menopause. It damages the pelvic floor and devitalizes the mucosal tone of the vaginal wall. These events often lead to the development of vaginal atrophy, dryness, reduced sexual satisfaction thus causing physiological distress, and affecting a woman’s quality of life, self-confidence, and sexuality. Its incidence is about 24-38% . This happens mostly in multiparous and postmenopausal women.

In ayurveda, many Sthanik chikitsa prescribed by ancient Acharyas such as Seka(vaginal douche), Abhyanga(massage) and Yoni pichu (vaginal tampon). Yoni pichu , a traditional ayurvedic practice, aims to address this issue and restore vaginal tone and elasticity.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
25.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • •Patients having 1 degree uterine prolapse with or without cystocele or rectocele, patients diagnosed with vaginal laxity on P/S or P/V examination, patients who is willing to take the treatment.

排除标准

  • •unmarried, pregnant women, infections of vulva,vagina and uterus, acute UTI, psychologically unstable, any benign or malignant growth in genital tract, 2nd and 3rd degree uterine prolapse and PID, having hormonal disorder like PCOS and congenital abnormalities of genital tract.

结局指标

主要结局

Improvement in vaginal laxity, tissue integrity and tone

时间窗: 0,3,5 WEEKS

次要结局

  • improvement in vaginal health parameters,(quality of life, sexual function & satisfaction)

研究者

发起方
Dr Khushbu kaushik
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验

尚未招募
Bioequivalence
左卡尼汀片在中国健康受试者中的人体生物等效性预试验本品适用于治疗原发性系统性左卡尼汀缺乏症。报道病例中,临床表现包括反复发作雷伊样脑病、低酮症性低血糖症和 / 或心肌病。相关症状包括肌张力低下,肌肉无力以及发育迟缓等。原发性左卡尼汀缺乏需要患者血清,红细胞和 / 或组织中的左卡尼汀水平低,并且患者没有原发性脂肪酸或有机酸氧化缺陷(见临床药理部分)。在部分患者,特别是表现为心肌病的的那些患者中,补充左卡尼汀可快速缓解疾病的症状和体征。除左卡尼汀外,还应根据患者病情予以支持治疗和其他治疗措施。 本品也用于由于先天性代谢异常导致的继发性肉碱缺乏症的短期和长期治疗。本品适用于治疗原发性系统性左卡尼汀缺乏症。报道病例中,临床表现包括反复发作雷伊样脑病、低酮症性低血糖症和 / 或心肌病。相关症状包括肌张力低下,肌肉无力以及发育迟缓等。原发性左卡尼汀缺乏需要患者血清,红细胞和 / 或组织中的左卡尼汀水平低,并且患者没有原发性脂肪酸或有机酸氧化缺陷(见临床药理部分)。在部分患者,特别是表现为心肌病的的那些患者中,补充左卡尼汀可快速缓解疾病的症状和体征。除左卡尼汀外,还应根据患者病情予以支持治疗和其他治疗措施。 本品也用于由于先天性代谢异常导致的继发性肉碱缺乏症的短期和长期治疗。
CTR20230185辽宁诺维诺制药股份有限公司24
已完成
不适用
左卡尼汀片在中国健康受试者中进行的人体生物等效性试验本品适用于治疗原发性系统性肉碱缺乏症。
CTR2024495212
已完成
不适用
左卡尼汀咀嚼片人体生物等效性试验原发性和继发性肉碱缺乏症
CTR2024397176
尚未招募
Unknown
枸橼酸西地那非片的人体生物等效性试验治疗勃起功能障碍治疗勃起功能障碍
CTR20200116济南明鑫制药股份有限公司86
已完成
不适用
左炔诺孕酮片人体生物等效性研究用于女性紧急避孕,即在无防护措施或其他避孕方法偶然失误时使用。
CTR2019202664